Organizational Study Report on

“IFIMED PHARMACEUTICAL PRIVATE LIMITED” at MYSURU.

SUBMITTED BY
Mr. CHANDAN D
(1NT21BA015)
Submitted to
VISVESVARAYA TECHNOLOGICAL UNIVERSITY,
BELAGAVI

In partial fulfillment of the requirements for the award of the degree of

MASTER OF BUSINESS ADMINISTRATION
Under the guidance of
INTERNAL GUIDE EXTERNAL GUIDE
Ms. JYOTHI G Mr. Yeshwanth P

Assistant Professor Area Manager

Department of Management Studies IFIMED Pharmaceutical Private Limited

Nitte Meenakshi Institute of Technology Manasara Road, Ittigegud

Bengaluru-560054 Mysuru-570010

NITTE MEENAKSHI INSTITUTE OF TECHNOLOGY

Department of Management Studies
BENGALURU-560064
2021-23
 NITTE MEENAKSHI INSTITUTE OF TECHNOLOGY

Department of Management Studies

P.B.NO 6429, Yelahanka, Bengaluru-560064

BONAFIDE CERTIFICATE

This is to certify that Mr. CHANDAN D bearing USN 1NT21BA015, is a Bonafide student
of master of business administration, 3rd semester NMIT, Bengaluru, affiliated to
Visvesvaraya Technology of University, Belagavi, organization report on “IFIMED
PHARMACEUTICAL PRIVATE LIMITED” Company is prepared by him under the
guidance of, Ms. JYOTHI G Assistant Professor, NMIT in partial fulfillment of requirement
for the award of the degree of Master of Business Administration of Visvesvaraya
Technology of university, Belagavi, Karnataka.

Ms. JYOTHI. G Dr. Shilpa Ajay Dr. H.C. Nagaraj

(Internal Guide) (HOD of MBA) (Principal)

 DECLARATION

As I am CHANDAN D student of 2ndyear MBA I hereby declare that I have prepared this
report on “IFIMED Pharmaceutical Private Limited”, Mysuru under the guidance of Ms.
Jyothi G, Assistant Professor of MBA department, Nitte Meenakshi Institute of Technology,
Yalahanka, Bangalore.

I also declare that this project is the result of my own efforts and has not been submitted
earlier to any other university or institution for the award of any degree or published any time
before.

Place: Bangalore Signature;

Date:
 ACKNOWLEDGEMENT

This piece of work is fruit of assistance of several people while it is impossible to mention all
by names, there are some whom the investigator particularly would like to thank.

First and foremost, we acknowledge our deepest gratitude to our Principal Dr. H.C Nagaraj
for their help to complete the project work. We would like to thank our parents for their
constant support and encouragement to complete this work successfully.

It’s my privilege to thank Ms. Jyothi G, Assistant Professor of MBA Department for her
valuable suggestions and advice while drafting this project work.

It’s my pleasure to thank the founder of “IFIMED PHARMACEUTICAL PRIVATE

LIMITED”, Mysuru found for granting the permission to do the project by giving a timely
guidance and co-operation as external guide.

I like to thank all of our friends, who are close to our heart, for supporting and helping us to
conduct this project successfully.

Thank you one and all

 Table of contents

CHAPTER CONTENTS PAGE NUMBER

PART-A
1 INDUSTRY PROFILE
1.1 Overview of the Industry

1.2 Nature of the Industry

1.3 Growth Potential

1.4 Influencing Economic Factor

1.5 Competitors’ Analysis

1.6 Market Share

1.7 Governmental Regulations

2 COMPANY PROFILE
2.1 Background of the Company

2.2 Promoters Information

2.3 Nature of the Business

2.4 Vision, Mission and Quality Policy

2.5 Achievements/Awards if any

2.6 Product Profile

2.7 Area of Operation

2.8 Future Growth and Prospectus

PART-B
3 McKinsey’s 7S frame work
3.1 Structure

3.2 Skill

3.3 Style
3.4 Strategy

3.5 System

3.6 Staff

3.7 Shared value

PART - C
4 SWOC Analysis of the company

4.1 Strength

4.2 Weakness

4.3 Opportunities

4.4 Challenges

PART - D
5 Financial Statement with Ratio Analysis.

PART - E
6 Learning experience

6.1 Reference

6.2 Annexure
LIST OF TABLES
LIST OF CHARTS
 EXECUTIVE SUMMARY
Numerous studies based on the different characteristics of the company are included in the
organizational study and are displayed in charts, analysis of data, infographics, table, and
statistics. This organizational analysis includes a description of the business's operations as
well. Some of the information is taken from trustworthy sources. This organizational study's
objective is to find significant information about organizations that will help the business
grow and function more effectively while also insuring its survival. The McKinsey 7's
Framework and SWOT analysis were only two of the many methods used in this
organizational research to assess the company. Information about the sector, the company's
makeup, its vision, mission, and quality policy, as well as its successes.

IFIMED encompasses the entire drug industry value chain as a responsible pharmaceutical
firm. It wants to establish a trail of new markets, innovative partnerships, intense client
centricity, and continued emphasis on developing differentiating competencies. IFIMED is
dedicated to providing top-notch medications for improved health and aspires to become a
significant pharmaceutical firm.

IFIMED has a fundamental obligation to patients, physicians, and everyone else who uses our
goods to suit their needs. We consistently strive to cut expenses in order to keep our rates
fair. We are equipped to meet this task, as are our channel partners. We have a duty to care
for the area where we work and live.

The many perspectives on how various types of individuals view the items in the market are
the main subject of this organizational study.
 PART-A
1. INDUSTRY PROFILE

The world's largest producer of generic pharmaceuticals, India is renowned for its low-cost
generic medicines and vaccinations. The Indian pharmaceutical sector is currently placed 3rd
in pharmaceutical output by volume, having evolved over time into a vibrant business
increasing at a CAGR of 9.43% over the last nine years. Vaccines, contract research &
manufacturing, biosimilars, and biologics are some of the key subsectors of the Indian
pharmaceutical business. Generic drugs, over-the-counter medicines, bulk drugs, vaccines,
and generic drugs are other important subsectors. India is home to the most US Food & Drug
Administration (USFDA)-compliant pharmaceutical production facilities, with 500 Active
Pharmaceutical Ingredients (API) companies accounting for around 8% of the global API
market.

Some of these projections include account for the potential cost of capital investments made
several years before profits are realized. These expenditures can add up to over half the
overall expense due to the extremely long period required for the research, testing, and
licensing of medications. Major pharmaceutical multinationals' tendency to outsource risks
associated with fundamental research has a direct impact on the pharmaceutical industry's
value chain. This trend slightly reshapes the industry ecosystem, with biotech companies
playing a progressively significant role, and overall methodologies are redefined
correspondingly. Some licensed medications, such as ones that use redesigned active
ingredients (sometimes known as "Line-extensions"), are produced at substantially lower
costs.

Over 50% of the world's demand for various vaccines is met by the Indian pharmaceutical
industry, as is 40% of the US market for generic drugs and 25% of the UK market for all
medicines. A total of 10,000 manufacturing sites and 3,000 medicinal businesses make up the
domestic pharmaceutical companies. India holds a significant place in the world's
pharmaceutical industry. The nation also possesses a sizable pool skilled scientists and
engineers that might propel the sector forward to new heights. Currently, Indian
pharmaceutical companies provide more than 80% of the antiretroviral medications needed to
treat AIDS (Acquired Immune Deficiency Syndrome) around the world. India has earned the
title of "pharmacy of the world" thanks to the affordable prices and superior quality of its
pharmaceutical products.

India's pharmaceutical market is presently valued at $50 billion. In September 2022, exports
of drugs and pharmaceuticals totaled US $2052.78 million, accounting for 6.29% of all
exports that month. In the fiscal year 2021–2022, the mean indicator of industrial production
for the manufacturing of medicines, pharmaceutical chemicals, and botanical goods was up
1.3%.

Drug and pharmaceutical exports totaled US $24.6 billion in 2021–2022, up from US $24.44
billion in 2020–21. From US $11.6 billion to US $24.6 billion, the Indian pharmaceutical
business experienced exponential growth between 2014 and 2022.

1.1 Overview Of The Industry

Industry of pharmaceuticals, Public and commercial entities engaged in the development,
production, and distribution of drugs and remedies. Historically, apothecaries later took over
the preparation of medications from doctors today, the discovery of new drugs depends on
the cooperation and work of highly qualified scientists at academic institutions and for-profit
businesses. The 19th century saw the beginning of the modern age of drug research and
development as researchers discovered how to purify and separate therapeutic chemicals and
created industrial manufacturing processes. Typhoid, poliomyelitis, and syphilis all were
considerably diminished in severity and frequency as our knowledge of biology and
chemistry advanced during the 20th century. While many medications, such quinine and
morphine, are derived from plant materials, others are found and created using processes like
chemical synthesis and recombinant DNA technology.

Medical advancement has been tremendously supported by the pharmaceutical business, and
numerous novel medications have been found and created in commercial laboratories. In
order to advance the management and eradication of disease, the pharmaceutical industry
must continually find novel medication targets, win regulatory approval, and improve drug
discovery procedures.

The pharmaceutical sector has grown to be a significant and intricate business. The majority
of the biggest pharmaceutical corporations in the world were based in North America,
Europe, and Japan at the turn of the century. Many of the biggest of these corporations were
international, with research, production, and sales occurring in many nations. Since the
pharmaceutical industry can be extremely lucrative, several nations are working to provide
the infrastructure required for drug businesses there to expand and engage in global
competition. Outsourcing also has come to represent the sector.

In other words, a lot of businesses engage specialized manufacturers or research

organizations to handle specific phases of something like the process of drug development on
their own. Some people attempt to keep the bulk of the procedures within their own business.
It is expected that the pharmaceuticals sector will continue to adapt and evolve through time
because it is primarily driven by money and rivalry, with each company vying to become the
first to discover cures for particular ailments.

1.2 Nature Of The Industry

India's pharmaceutical sector contributes significantly to the country's exports and has
attractive prospects for investment. India also runs a sizable number of facilities that uphold
to Good Manufacturing Procedures (GMP) norms established by the World Health
Organization (WHO) and the United States Food and Drug Administration. Millions of
people around the world receive affordable and low-cost generic medications from India
(USFDA). India has traditionally retained the top position among countries that make
pharmaceuticals. Over the next 5 to 10 years, India's medical spending is expected to increase
by 9–12%, making it among the top ten countries in the world.

Better domestic sales growth in the future would also depend on companies' capacity to focus
their product portfolios on chronic treatments for prevalent ailments including cancer,
diabetes, depression, and cardiovascular disease.

To cut costs and lower healthcare prices, the Indian government has undertaken a number of
actions. The India's National Health Protection Scheme, which aims to provide socialized
medicine, the elderly workforce, the rise in chronic illnesses, and other government
initiatives, such as the creation of pharmacies that offer low-cost generic pharmaceuticals,
should all help to strengthen the Indian pharmaceutical business.

The quick entry of generic medications into the market has remained a priority and is
anticipated to help Indian pharmaceutical companies. Additionally, the focus on preventive
immunizations, life-saving medications, and rural health programs bodes positively for the
pharmaceutical industry. Since the start of the 11th Plan in 2007, the Indian pharmaceutical
industry has expanded significantly, increasing from around ₹71,000 crores to over ₹1
million crores in 2009–2010, with over ₹62,055 crores of home economy and over ₹42,154
crores of exports. Additionally, this provides for around 20% of all generic drug volume
worldwide.

The sector, which has about 10,500 units with the bulk operating in the unorganized sector,
is, nevertheless, quite fragmented. About 300 to 400 of these are classified as being part of
the medium-sized organized sector, with both the best ten firms holding 36.5% of the share of
the market.

Regarding the industry's bulk medicine segment, the market is estimated to be worth roughly
₹42,000 crores, or about 50% of the entire domestic market. This results in an approximate
9% share of the market for the Indian bulk medication sector.

India is one of the top twenty exporters of pharmaceuticals, and during the 11th plan period,
exports increased dramatically at a CAGR of almost 19%. Throughout 200 countries around
the world with heavily regulated markets, such as the USA, UK, and many others, import
drugs from India. Anti-infective, anti-asthmatic, and anti-hypertensive medications are the
three main therapeutic subcategories exported.

1.3 Growth Potential

• Efficiency in Cost: The effectiveness of Indian pharmaceutical businesses is

increased by their low production costs and R&D, which results in competitive
exports. Indian pharmaceutical and medicine exports totaled US $24.60 billion in
FY22 and US $24.44 billion in FY21.

• Financial Drivers: The high rate of economic growth in India and the growing use
of health insurance will drive up costs for medicine and healthcare.

• Defend Policy: A further expenditure of ₹197,000 crore (US $26,578.3 million)

was made public by Finance Minister Ms. Nirmala Sitharaman in June 2021. This
money will be used over five years for the Pharma PLI scheme in 13 crucial sectors,
including active pharmaceutical ingredients drug intermediaries, and important
starting materials.

• Investment Growth: Between April 2000 and March 2022, FDI inflows into the
Indian medicine and pharmaceutical industry totaled US $19.41 billion
 1.4 Influencing Economic Factor.

• According to the Union Budget for 2022–23, research would receive ₹3,201 crore
(US $419.2 million) and the Ministries of Health and Family Welfare will receive
₹83,000 crore (US $10.86 billion).

• The "National Health Mission" has received a budget of ₹37,000 crore (US $4.83
billion)

• Pradhan Mantri Swasthya Suraksha Yojana has received funding in the amount of
₹10,000 crore (US $1.28 billion).

• The amount allotted to the Ministry of AYUSH has increased from ₹2,970 crore (US
$389 million) to ₹3,050 crore (US $399.4 million).

• In order to permit FDI up to 100% under the government route for the production of
medical devices subject to specific restrictions, the Union Cabinet has authorized a
change to the current Foreign Direct Investment (FDI) strategy in the pharmaceutical
industry.

• The Indian government gave the pharmaceutical and healthcare sectors US $4 billion
in September 2021.

1.5 Competitors’ Analysis

It's critical to consider competitors' behaviour and mind set. Strategic planning often includes
competitive analysis, and the resources of such Web content are continually updated and
enhanced. It is impossible to reconcile the information already available in order to respond
to fundamental questions about its income, operations, and recommendations because this
broad attraction has evolved into several meanings, conceptual frameworks of recognized
contender proof, as well as numerous thinking styles.

It is vital to look at things that are actually working in the field if you want to battle with the
resistance that organizations are up against. Learn about the limitations of relying on
measurable study, which are quite clear as strict. More recommendations may be made,
which would be profitable for the association.

The examination of the rivals offers both offensive and defensive strategy to find threats and
opportunities. Benchmarking incorporates all pertinent competition evaluation resources into
a single framework to help the efficient and effective formulation, execution, evaluation, and
modification of approaches.
The 10 leading pharmaceutical companies in India are closely monitored in this endeavor.
According to overall revenue, or general income, the absolute positioning awards.

Rankings based on analysis of comparison and the aforementioned factors are as follows:

1. Sun Pharma.
2. Aurobindo Pharmaceutical Ltd.
3. Lupin.
4. Cipla.
5. Doctor Reddy's.
6. Cadila Healthcare Limited.
7. Intus Pharmaceuticals Limited.
8. Glenmark Pharmaceutical Ltd.
9. Orrent Pharma Ltd.
10. Mankind Pharmaceuticals Ltd.

1.6 Market Share

In the coming ten years, the national market is anticipated to rise by three times, in
accordance with the Indian Economic Report 2021. The domestic pharmaceutical market in
India was estimated to be worth 42 billion in 2021 and is projected to rise to US$ 65 billion
by 2024 and US$ 120–130 billion by 2030. Biopharmaceuticals, bio services, bio agriculture,
bio industry, and bioinformatics are all part of India's biotechnology sector.

In 2020, the Indian biotechnology market was estimated at $70.2 billion, and by 2025, it is
anticipated to grow to $150 billion.

The market for medical equipment in India was valued at $10.36 billion in FY20. Between
2020 and 2025, the market is projected to grow at a CAGR of 37%, reaching US$ 50 billion.

As of September 2021, CARE Ratings anticipates that India's pharmaceutical industry will
grow at an average annual rate of 11% over the following two years to achieve a value of
more than US$ 60 billion.

The capacity to take advantage of the chance presented to Indian pharmaceutical companies
as patents on medications around the world expire, the abating of regulatory risks, the
adoption of various measures to reduce the risk associated with reliance on China for
essential raw materials, the rising trend in Portfolio investment, and the industry's strong
fundamentals are the primary reasons that are anticipated to propel industry growth.
India is a prominent and developing player in the global pharmaceutical companies. India is
the biggest producer of generic drugs in the world, contributing 20% of the total volume
supply and 60% of the demand for vaccines worldwide. Worldwide, the pharmaceutical
industry in India is valued $42 billion. The Indian pharmaceutical market grew by 17.7%
annually in August 2021 compared to a 13.7% growth rate in July 2020. Indian
pharmaceutical industry revenue is anticipated to increase by more than 12% year over year
in FY22, thus according India Ratings & Research.

1.7 Governmental Regulations

The Ministry of Health and Family Welfare of the Government of India established the Drugs
Controller General of India ("DCGI"), which is the central organization responsible for
overseeing all aspects of the country's drug market, including clinical studies, market
authorization, and post-market surveillance. Additionally, it evaluates clinical trial conduct,
Good Manufacturing Procedures (GMP) accreditation, and approval for import, production,
sales, and distribution.

The Central Drug Standard Control Organization is led by the DCGI, which also sets
strategies to carry out the Drugs Act. The actions of the several State National Drug
Organizations are likewise coordinated by the DCGI.

The import, manufacture, licensing, examination, distribution, and the sale of drugs in India
are all governed by the Drugs and Cosmetics Act, 1940 ("Drugs Act") and the Drugs Rules,
1945 ("Drugs Rules"). A medicine must adhere to specific quality requirements in order to be
imported, produced, stocked, sold, or distributed, as stated by the Drugs Act.

The label, container, and other criteria for the product must display the components in the
manner required by the Drugs Rules. Concerning pills, capsules, liquid orals, injections, and
ointments, general guidelines have been established.
The National Pharmaceutical Pricing Authority (NPPA), established in 1997 under the
Department of Chemicals and Petrochemicals, tries to fix or rethinks the rates of deregulated
bulk drugs and formulations at judicious intervals, updates the list of drugs subject to price
control on a regular basis by including and excluding drugs in accordance with established
guidelines, maintains data on production, exports and imports, and market share of
pharmaceutical firms, and enforces price control laws.

The Ministry of Chemicals and Fertilizers implements the NPPA's recommendations for
setting the API ceiling price and issuing notifications for formulations and medications that
are scheduled pharmaceuticals. The Order gives the Indian government the authority to
recoup fees that businesses charge that are in excess of the announced prices.

To ensure adherence to this directive, any place may be entered, searched, and any drugs may
be seized by an officially designated Officer of the Central Government or State Government,
as designated for the purpose of this Act. Any violation of this Order's rules will be punished
underneath the Essential Commodities Act's rules.
 2. COMPANY PROFILE

IFIMED covers each element in the pharmaceutical industry's value chain as a responsible
pharmaceutical company. It establish a track history of opening up new markets, forming
innovative alliances, being extremely focused on our customers, and consistently enhancing
our unique capabilities.

It strive to improve people's lives all over the world via our dedication to accessible, cutting-
edge healthcare. Through our customer-centric strategy and relationship-focused marketing,
we "think we have the potential to satisfy healthcare demands in both existing and new
markets quickly and effectively."

IFIMED is dedicated to providing top-notch medications for improved health and aspires to
become a significant pharmaceutical firm.

2.1 Background of the Company

On August 9, 2012, a private company called IFIMED pharmaceutical was established. It is
registered with the Bengaluru Registrar of Companies as a non-government company. It has a
₹25,000,000 authorized capital as well as a ₹25,000,000 paid up capital.

On September 30, 2022, IFIMED Pharmaceutical conducted its most recent annual meeting
of shareholders. Its most recent balance sheet was submitted on March 31, 2022, according to
records from the Ministry of Corporate Affairs.

Out of 62 businesses In Karnataka, IFIMED, the 57th-oldest business, specializes in the

marketing and distribution of medical and pharmaceutical supplies.

IFIMED, which is initially engaged in wholesale of healthcare and pharmaceutical items in

India, is the 1398th oldest company out of 1705 firms.
 2.2 Promoters Information
ANANTHARAAMAIAH SUDEENDRA is a co-owner and serves as Managing Director in
IFIMED pharmaceuticals from 9th August 2012. He also hold Directorship in NECTAMED
laboratories LLP from 28th September, 2017. He draws gross salary of ₹13, 07,040.

PAVITHRA PRABHUDEV is a co-owner and act as Director in IFIMED pharmaceuticals

from 9th August 2012. Her gross salary from IFIMED amounts to ₹10,666,780.

Govindaraju & Shanthakumar is a firm of Chartered Accountant, C.A K Keshava Dongre

FCA., audited and look after the accounts of IFIMED Pharmaceuticals.

2.3 Nature of the Business

Corporate Identity Number (CIN) of U51397KA2012PTC065239

company

Name of the Company IFIMED PHARMACEUTICAL PRIVATE

LIMITED

Date of Incorporation 9th August 2012

Address of the Company NO. 83/D, Ground Floor, Opposite Jain Temple

Manasara Road, Ittgegud, Mysuru -570010

Registrar of Company ROC Bengaluru

Registration Number 065239

State Karnataka

E-mail Id [email protected]

Product or Service category code 9961

Description of the product or service Wholesale of pharmaceutical and medical goods

category

Company category Company Limited By shares

Company Sub category Indian Non-Government Company

Class of Company Private

Authorised Capital ₹25,00,000/-

 Paid-up Capital ₹25,00,000/-

Number Of employees 25

Revenues ₹4.11 Crores

Company website https://www.ifimed.com

Company Status Active

IFIMED Pharmaceuticals Private Limited does not routinely manufacture medications in

their own facility. The business has contracted with various states, including Himachal
Pradesh, Pondicherry, Jharkhand, Tamil Nadu, and Hyderabad, to provide pharmaceutical
products for sale to distributors.

2.4 Vision, Mission and Quality Policy

Vision Statement: The position that the business aspires to achieve in the future, a vision
statement gives an organization's goals for the future. The top management, which may
include the CEO, CFO, managing director, etc., draughts a vision statement. It establishes a
framework for promoting the development of mutually beneficial relationships between the
organization and stakeholders.

Mission Statement: An organization's motivation for existing is outlined in its mission

statement. It details the organizational values and culture and establishes the principles that
should be followed when completing tasks. A mission statement is a specific declaration that
specifies its goods, markets, and geographic reach of the business, as well as market price,
etc.

Quality Policy: A short document created as part of a company's quality management system
is called a quality policy statement. It identifies what your organization considers to be
"quality" and describes the procedures you have now in place to make sure you adhere to the
set standards.

Vision, Mission and Quality Policy of IFIMED Pharmaceuticals Private

Limited.

Vision
We believe in providing high quality, affordable and innovative panacea in medicine and
treatment with deep responsibility for its contribution toward public health sector.
Mission

We shall provide total customer satisfaction and achieve leadership in chosen markets,
products and services across, be responsible and consciously commit to social and
environmental causes.

Quality Policy

Considering that pharmaceutical products directly affect people's lives and health. Quality
control will always be a top priority for IFIMED Pharmaceutical Private Limited.
Pharmaceutical production environments that adhere to WHO-GMP (Good Manufacturing
Practice) standards are used to create high-quality products. In all company activities,
including manufacturing, collection, and provision of product safety and welfare and
efficacy, it is essential to assure product high quality. While doing so time, however, we must
adhere to all applicable laws, ordinances, rules, and regulations.

IFIMED Pharmaceuticals Private Limited bases its quality management system on the
following tenets:

• A clear and documented process.

• Clearly defining who is responsible for what.
• Ongoing development.
• Regulated manufacturing procedure.
• Employee safety is continually monitored by educated and trained personnel.

2.5 Achievements/Awards if any

IFIMED holds Certificate from World Health Organization for Manufacturing of

Pharmaceutical goods.
IFIMED Pharmaceutical private Limited recognized as Star Export house from the
Government of India.

IFIMED Pharmaceutical Company have the ISO 9001:2008 Certificate which ensures Total
Quality Management in manufacturing of pharmaceutical items.

IFIMED holds the membership of Indian chamber of commerce, which helps to manufacture
and distribution of pharmaceutical items all over India.
IFIMED Pharmaceutical Company holds the membership of Pharmexcil which helps to
export of some pharmaceutical item of IFIMED to the other foreign countries.

2.6 Product Profile

IFIMED offerings include medications for the administration of intestinal health, pain,
allergies, and we have a solid plan again for introduction of new brands fairly shortly. Our
extensive product portfolio encompasses every aspect of living while also meeting crucial
health standards.

Two medications that both aid in lowering blood pressure are included in Cidney T
10mg/40mg Tablet. Through lowering blood pressure and facilitating easier blood circulation
through the body, it decreases blood pressure. Your probability of suffering a stroke or heart
attack will go down as a result.
Vitamin D and calcium deficiencies are treated with Cal break Tablet. Osteoporosis and other
bone-related conditions are treated with it. In particular populations including the elderly,
expectant, and nursing mothers who require calcium and vitamin D supplements, it is also
used.

A combination drug called Beta cold Tablet is used to treat cold symptoms like runny nose,
fever, and nasal congestion. It combines the three active substances phenylephrine, cetirizine,
and paracetamol.
A prescription drug called IFISPAS 50mg/20mg Tablet aids in relieving the discomfort and
cramps associated with menstruation (periods). By decreasing stomach and intestinal
muscular spasms, it can also be used to relieve abdominal pain.

As for treatment and avoidance of various anaemia’s. for the purpose of avoiding iron, folic
acid, vitamin B12, and zinc deficiency during pregnancy, breastfeeding, following surgery, or
in situations where dietary absorption is compromised. As a dietary addition.
A combined drug called Knead Gel is applied topically to control the pain. It functions by
preventing the production of specific chemical messengers that induce inflammation and
pain. It also has a cooling impact on the skin and enhances blood flow at the application
location.

Povidone-iodine is an iodophore having potent broad-spectrum germicidal activity against a

variety of bacteria, viruses, fungi, protozoa, and spores. Microbicidal; oxidizes cell
components; iodinates proteins and renders them inactive.
Algiace SP Tablet is a combined drug used to treat a variety of pain and swelling-related
issues, include post-operative pain, joint pain, and muscular pain. As a result, it effectively
reduces discomfort and swelling in diseases like osteoarthritis, psoriatic arthritis, and
rheumatoid arthritis.

A medicine called IFIRAB 20mg Tablet lessens the quantity of acid your stomach produces.
It is used to treat illnesses of the gastrointestinal tract caused by excess acid secretion,
including acid reflux, ulcer disease, and a few other stomach problems.
If used as soon as the first signs of pain appear, Tralgia P 37.5mg/325mg Tablet successfully
treats moderate to severe pain associated with illnesses such as menstrual cramp, arthritis,
headaches, and muscular aches. It functions by reducing the levels of pain-causing chemicals
in the body. This enhances your life quality by providing pain and discomfort alleviation.

As a member of the calcium channel blocker drug class, Cidney-20 mg Tablet 10s is
primarily used to treat angina and hypertensive (high blood pressure) (chest pain). The force
that the blood exerts on the arterial walls increases with hypertension (high blood pressure), a
lifelong or chronic condition. The heart must work harder to pump blood at higher blood
pressure.
 2.7 Area of Operation
Clients of IFIMED include both patients and important figures in the pharmaceutical sector.
It guarantees that information is always correct, relevant, and medically validated. To
promote its pharmaceuticals products to the end customers, IFIMED pharmaceuticals Pvt. ltd.
works internalization and outside of states in India. IFIMED pharmaceuticals also is active in
the online pharmaceutical companies with firms like TATA 1Mg, Pharm Easy, Med life, and
many more.

2.8 Future Growth and Prospectus

Beginning on August 9th, 2012, IFIMED Pharmaceuticals Private Limited began operations.
Since its inception, IFIMED has been up against fierce industry competition. However,
IFIMED started to gain market share through its aggressive and strategic program after a
specific period of time.

IFIMED Pharmaceuticals Private Limited. Profit in ₹ (Lakhs) from

2018 to 2022.
50
₹44.36
45
40
Profit in ₹ (Lakhs)

35 ₹30.09
30
25
20 ₹16.98

15 ₹10.6
₹8.5
10
5
0
2018 2019 2020 2021 2022

Years

IFIMED Pharmaceutical Private Limited possesses all the necessary elements, such as a
qualified staff, low production costs, high levels of managerial and technological expertise,
and much more, to succeed in the worldwide market. Additionally, IFIMED offers a
significant number of job candidates a vast array of career prospects. The future of the Indian
pharmaceutical business is thus undoubtedly bright, as would be appropriate to state about
IFIMED Pharmaceutical private Limited.
 PART-B
3. McKinsey’s 7S frame work
An international management consulting business that works with both public and private
companies is McKinsey. It was established in 1926 and has its main office in New York,
USA. Famous business consultants Tom Peters and Robert H. Waterman (junior) created the
McKinsey 7S Framework as a management model/tool in the 1980s.

This was a strategic goal for organizations, including firms, divisions, and teams. Structure,
strategy, systems, skills, style, staff, and shared values make up the seven S's.

This paradigm is most frequently used as a tool for the management analysis to evaluate that
track changes in a company's inner environment.

The concept is founded on the idea that these take a holistic approach must be coordinated
and supportive of each other in order for an organization to function effectively.

In order to increase performance, the paradigm can be used to determine what has to be
realigned. It can also be employed to keep harmony and performance during the other sorts of
change.

The model can be utilized to understand how the organizational elements are interrelated and
make sure that now the broader impact of modifications made inside one region is taken into
consideration, regardless of the type of transformation, new processes, organizational
merger/acquisition, new platforms, change in leadership, etc.

Objectives of McKinsey’s 7S frame work in IFIMED Pharmaceuticals

Private Limited.
• Improve company’s performance.
• Investigate the possible outcomes of upcoming changes within association.
• Align units and procedures during such a merger or acquisition.
• Ascertain the finest way to carry out a proposed strategy.
• It is employed to evaluate how well a firm's current and suggested strategies align
strategically.

SEVEN INTERDEPENDENT ELEMENTS:

The model's fundamental tenet is that a company must have alignment in seven internal areas
in order to succeed.
HARD ELEMENTS:
"Hard" aspects are simpler to spot and can be directly influenced by management. These
include mission and vision statements, organizational structures, reporting lines, formal
procedures, and IT systems.

• Structure:

The organizational structure and who is responsible for what.

• Strategy:

The strategy designed to retain and increase the company's competitive advantage.

• Systems:

The routine tasks and processes that employees follow to complete their jobs.

Because they are linked to the core and most important components of the organization, these
are referred to as hard components. The organization chart, corporate plans, and declaration
of strategy all contain these concrete, easily recognizable hard elements.
SOFT ELEMENTS:

The more intangible and culturally affected "soft" elements can be harder to define and
describe. Nevertheless, if the company is to succeed, these soft elements are just as crucial as
the hard elements.

• Staff:

The staff and their overall competencies.

• Skills:

The actual skills and competencies of the employees working for the company.

• Style:

The leadership approach used in the company.

• Shared Values:

These are referred to as "Superordinate goals." These were the company's key ideals, which
are reflected in the organizational culture and overall work ethic, when the model first was
created.

IFIMED Pharmaceuticals Company Private Limited is using the McKinsey

7s framework.

1. STRUCTURE:

Structure depicts the organization of a company's divisions and units and specifies who is in
charge of what and who is accountable to whom. Structure can also be thought of as the
firm's organizational chart. Additionally, it is one of the most noticeable and versatile
components of the framework. A company can give a hierarchy that outlines roles,
responsibilities, and oversight thanks to organization culture.

Organizational structures usually employ one of the following two methods:

• A centralized system that places the bulk of the power and decision-making power in the
hands of the top management team.

• A decentralized structure, such as departments, groups, or business units, which distributes

authority and decision-making power at lower levels.
A organization can be set up in a variety of ways. It may be constructed using a matrix
technique or around divisions, functions, or geography.

The Organizational Structure of IFIMED Pharmaceutical Private Limited.

MANAGING DIRECTOR

DIRECTOR

HUMAN R&D
FINANCE MARKETING PRODUCTION
RESOURCE
DEAPRTMENT DEPARTMENT DEPARTMENT DEPARTMENT
DEPARTMENT

The organisation structure used by IFIMED Pharmaceutical private limited is Flat and
Functional in Structure. It aids the IFIMED in executing its responsibilities more
successfully and effectively.

• Finance Department:

Keeping all financial records and the accounts books for sales, purchases, and other financial
transactions are some of the duties of the finance department of IFIMED.

• Marketking Department:

Aside from quality concerns, IFIMED Pharmaceutical's marketing division identifies the
cause and origin of consumer difficulties. Evaluating the general competitive environment
and offering more trustworthy "FEED-BACK" to support quality control.
 • Production Department:

IFIMED Pharmaceuticals Private Limited does not routinely manufacture medications in

their own facility. The business has contracted with various states, including Himachal
Pradesh, Pondicherry, Jharkhand, Tamil Nadu, and Hyderabad, to provide pharmaceutical
products for sale to distributors.

• Human Resource Department:

IFIMED Pharmaceutical's HRM department ensures sure that human resources are used to
their full potential. Maintaining the workforce to adapt to modernization and technological
advancement. Assuring high productivity while streamlining sporadic worker supply
disruptions to meet corporate functional needs.

• Research and Development Department:

IFIMED employs about 20 researchers who operate in R&D facilities that are outfitted with
cutting-edge research technology. Our researchers are skilled at creating generic items that
range from being challenging to requiring a lot of technology, as well as Active Pharma
Ingredients (API), Novel Drug Delivery Systems (NDDS), and New Chemical Entities
(NCE).

2. STRATEGY:

A strategy is an action plan created to preserve and expand a competitive edge over rivals.
Simply put, strategy can be described as the organizations overall definition or plan.

It outlines important initiatives and strategies for managing alliances and partnerships,
developing products and services, and marketing on a broad scale. It outlines a company's
strategy for realizing its goal and addressing the advantages and disadvantages of the new
media. It is the path that the business has chosen for its continued growth in order to meet
customer needs while fending off challenges from rivals. It entails the formulation and
execution of significant initiatives and goals taken by senior management in behalf of other
the company's stakeholders.

IFIMED Pharmaceuticals uses the following important tactics, among others:

• Targeted Strategy: IFIMED concentrates on key players in the pharmaceutical sectors

• Broad: IFIMED is present in every nook and cranny of India.

• Product Diversification: IFIMED offers a large selection of pharmacy products to meet the
demands of its clients.
• Smart Marketing: According to IFIMED, it aims to elevate its product marketing and
communications.

• Product Improvement & Guaranteed Quality: IFIMED manufactures high-quality goods to

satisfy all involved parties with its R&D facilities.

3. SYSTEM:

A system is defined as a method or a phase of procedures that links and organizes activities to
make it possible to work toward the desired outcomes. The efficacy and efficiency of the
organization in attaining its goals is influenced by the identification, understanding, and
management of processes as a system.

The staff members' regular tasks and routines are what enable them to do their work. All
daily activities at IFIMED Pharmaceuticals are pre-planned using cutting-edge technology,
and they have put in place systems like:

• Total Quality Management (TQM) Management:

Total Quality is upheld in accordance with corporate standards from the time raw materials
are purchased to the time finished items are delivered to clients. Production uses the Quality
Assurance Process Control System.

• SAP ERP (Enterprise Resource Planning):

For the efficient administration and fusion of all its business activities, IFIMED Pvt. Ltd has
installed the SAP (Systems, Applications and Products) system.

4. STAFF:

Staff alludes to the workers and their broad range of competencies. Humans make up
organizations, and in the progressively knowledge-based world, it is the people who
contribute most to the achievement of the company's goals.

As a result, human resources now hold a key role in the organization's strategy, taking the
place of the capital and land-based traditional model.

The hiring process involves a number of steps, including training, recruiting, and selection
procedures. The development, training, socialization, integration, motivation, and shaping of
an employee's career inside a company are all included by this term.

IFIMED Pvt Ltd staffing also describes the amount and diversity of employees inside a
business as well as the methods used to instil core values in workers.
 Number of Employees in IFIMED Pharmaceuticals Private Limited

DESIGNATIONS NUMBERS OF EMPLOYESS

Managing Director 1
Director 1
Chief Accounts Manager 1
General Manager 5
Area Manager 8
Territory Manager 6
R&D Staff 3
Total 25

The business ensures that its employees are happy by offering the necessary amenities, such
as:
1. Employee transportation
2. Training
3. Health and safety measures
4. Inspiration
5. Fair Compensation
6. Respect, and
7. Equal Opportunities

5. SKILLS:
The term "skills" refers to the genuine skill and abilities that workers of the organisation
possess. They are forced to integrate the business's strategy. Every person has a unique
capacity or ability that he may use to perform his tasks successfully. Each employee
possesses a variety of abilities, thus it is the responsibility of the business to understand these
skills and put them to effective and efficient use.
It speaks to the qualities one has to have in order to carry out a specific task. It contains the
characteristics that a firm wants its employees to possess in order to carry out the task at hand
effectively.
The question of what capabilities the organisation will actually need to support its new
approach or new structure and assure the company's success frequently emerges throughout
organisational transformation.

The following table lists the numerous abilities, specialisations, and character qualities that
workers of IFIMED Pharmaceutical firms possess.
 Profile Competency Is Required
Chemist Analysis Capabilities, Paying Attention to Details Technical
Skills.

Manufacturing Analysis Capabilities, Paying Attention to Details Technical

Technician Skills.
Medical Representative Communication abilities, Product Knowledge, Selling Prowess,
Focused on Results and Possibility of Managing Pressure.

The following are some additional skills that staff of IFIMED possess:
• Technical expertise.
• Behavioural knowledge and experience.
• Business leadership.
• Teambuilding.
• Behavioural skills and
• Communication skills.

6. STYLE:
It has to do with how senior executives run the business, how they communicate, what they
do, and how significant they are to the organisation. It may be summed up as the leadership
style of the company.
It is entirely focused on the company's leadership as well as how the organization's personnel
represent themselves to the outside world. The company's staff adheres to a same manner of
learning, thinking, and acting.
Every business has a unique culture and management approach. It encompasses the
prevailing ideals, convictions, and conventions that evolve through time and essentially
endure as aspects of organisational life. It also includes the manner in which managers
engage with employees and how they spend all their time.
Because directors as well as other authorities are the ones who make decisions based on their
opinions and assessments, IFIMED Pharmaceuticals private limited demonstrates an
AUTOCRATIC Type of Leadership. This management style aids in maintaining discipline
and order rapid decision-making, efficient work processes, and tight monitoring. Target-
oriented thinking is beneficial. This method aids IFIMED Pharmaceutical in producing
results without errors.
 7. SHARED VALUES:
"Super ordinate aims" is another name for shared ideals. These were the company's key
ideals, which are reflected in the company culture and overall work ethic, whenever the
model was initially created.

Trust is created by the prevailing assumptions, mind-sets, and shared values that influence
how a business operates and its corporate culture. They serve as the hub of connectivity for
the seven values that make up the identity of a firm throughout all of its functional domains.

A shared value is a crucial quality or feature that the organisation promotes to influence how
its members behave. Shared value is centred on maximising the market competitiveness of
resolving social issues with new clients and markets, lowering expenses, retaining talent, and
other factors.

Companies now place a greater emphasis on developing their brand through a set of shared
values since doing so improves their standing in society. IFIMED Pharmaceuticals Private
Limited's major goal is to offer high-quality, reasonably priced goods with an emphasis on
environmental protection.

IFIMED Pharmaceuticals adheres to the following values:

• INTEGRITY:

Being truthful with their customers, staff members, the individuals they encounter with, and
most significantly, with their job.

• CUSTOMER FIRST:

IFIMED Pharmaceuticals' survival is based on its customers. Their web design department
offers their customers a range of suggestions and guidance so they may collaborate with them
to create a suitable solution that surpasses their industry requirements.

• TEAM WORK:

IFIMED Pharmaceuticals thinks they can do more on their own, but they know the results
will be greater with another pair of eyes, a different perspective, and a different person
standing by their side.

• QUALITY:

IFIMED Pharmaceutical continually prioritises quality and seeks to build lasting relationships
with our clients based on these three values: Quality, Trust, and Effort.

In addition, IFIMED Pharmaceuticals adheres to the following values:

• Taking advantage of technical progress.
• The desire for superiority.
• Business practises that are moral.